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Abstract 
The patient was a 74-year-old man suffering from tuberculotic chronic pyothorax. He had 
hematemesis in January 2006. Hb was 6.1 g/dl. A type 2 tumor 3 cm in diameter was 
found in the vaulted region on the greater curvature side. It was diagnosed as a 
malignant lymphoma. WBC and differential count were normal, and the patient tested 
negative for HTVL-1 antibody. sIL2-R was elevated to 1,500 U/ml. The superficial lymph 
nodes were not palpable. CT examination was not remarkable for the liver and spleen. 
There was no generalized lymph node enlargement. Based on these findings, a diagnosis 
of malignant lymphoma of gastric origin was made. As the patient had respiratory 
disorders, too, wedge-shaped gastrectomy was performed to inhibit invasion. 
Pathological examination revealed CD3 positive large atypical lymphocytes diffusely, EBV 
positive, HP negative. As a result, a diagnosis of non-Hodgkin T-cell lymphoma was 
made. The tumor did not return for 1 year and 8 months after surgery, but the patient 
died of sudden aggravation of respiratory disorders in September 2007. Pathological 
anatomy was performed. The gastric remnant was left with lymphoma, and the bone 
marrow and systemic lymph nodes were negative for a malignant lymphoma. The 
possibility of stomach metastasis from the preoperative pyothorax-related malignant 
lymphoma was considered, but was ruled out because the lungs were devoid of a 
malignant lymphoma. We report a case of an extremely rare malignant T-cell lymphoma 
of gastric origin. 
 
Introduction 
Malignant gastrointestinal lymphoma usually originates from the stomach and is 
mostly derived from B cells and rarely from T cells [1]. We treated a patient with  
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malignant T-cell lymphoma of gastric origin accompanied by chronic tuberculous 
pyothorax, which required differentiation from gastric metastases of adult T-cell 
leukemia/lymphoma, EBV-associated malignant lymphoma, which is also known as 
pyothorax-associated lymphoma (PAL) [2, 3], and primary effusion lymphoma (PEL) [4]. 
Case Report 
The patient was a 74-year-old man with the chief complaints of hematemesis and anemia. He had a 
history of tuberculous pleurisy. He had smoked 50 cigarettes daily for 50 years or more. In May 2005, he 
was hospitalized with pneumonia and acute heart failure. Thoracic drainage was performed because of 
right pyothorax. He had been suffering from chronic arteriosclerosis for 6 years and had been on 
anticoagulant therapy since a stent was inserted into his left external iliac artery in July 2005. In January 
2006, hematemesis occurred, but he did not seek treatment. When he attended the outpatient clinic in 
February 2006, his Hb was 8.0 g/dl. Subsequently anemia progressed (Hb 6.1 g/dl) and black stools were 
noted. He underwent gastroscopy and was hospitalized because a tumor was detected on the greater 
curvature of the gastric body. 
On admission, there was obvious anemia and breath sounds were reduced on the right side. The 
abdomen was flat and hepatosplenomegaly was not detected. Hb was 6.1 g/dl, suggesting severe anemia, 
but the differential WBC count was not abnormal. CEA was slightly increased to 6.1 ng/ml. The patient 
was positive for EBV antibody and negative for HTLV-1/HIV antibodies, while sIL2-R was elevated to 
1,500 U/ml (table 1). 
Chest X-ray revealed a lesion protruding into the thoracic cavity from the right chest wall, which was 
probably a pyothorax, and a nodule in the left upper lung field (fig. 1a). Abdominal X-ray showed no 
abnormalities other than pyelectasis. Gastroscopy revealed a sharply defined prominent lesion 
approximately 3 cm in diameter located at the fornix of the stomach. It was a type 2 tumor with a 
central ulcer (fig. 2a). The patient was negative for Helicobacter pylori. Biopsy strongly suggested that 
the tumor was a malignant lymphoma. Chest and abdominal CT showed a collection of fluid 
surrounded by calcified and thickened pleura on the right lower chest wall, which was thought to be an 
old pyothorax (fig. 1b). In the abdomen, there was a contrast-enhanced tumor on the posterior wall of 
the gastric fornix (fig. 2b), but there were no abnormalities of the liver or spleen and perigastric 
lymphadenopathy was not detected. Ga scintigraphy noted increased uptake in the mediastinum. Iliac 
marrow aspiration biopsy showed CD3-positive lymphocyte-like cells in some areas. Otorhinological 
examination revealed nothing abnormal. Potential sources of hemorrhage were not detected in any 
other part of the gastrointestinal tract.  
Based on these findings, malignant T-cell lymphoma of the stomach was diagnosed. It was stage IV 
according to the Cotswolds classification [5], but whether it was primary or secondary was unclear. 
Since anemia progressed and the patient had a history of respiratory impairment due to chronic 
pyothorax as well as pneumonia and acute heart failure, invasive surgery was performed in March 2006 
to remove the source of hemorrhage. Laparotomy was performed by making a median incision in the 
upper abdomen. Ascites was not noted, and there were no abnormalities of the liver or spleen. Since 
there was no perigastric lymphadenopathy, wedge resection of the stomach was performed to remove 
the tumor. 
Macroscopic observation revealed a prominent tumor 3 cm in diameter with an ulcer at its center 
located slightly towards the posterior wall on the greater curvature of the gastric fornix, which was of 
the collapsed type according to Sano’s classification. Within the tumor, large atypical lymphocytes 
showed diffuse proliferation, and the depth of invasion was classified as subserosal (fig. 3a). 
Immunohistologically, the tumor was positive for CD3 (fig. 3b), while it was negative for CD20, CD56, 
and CD57. Therefore the patient was diagnosed as having non-Hodgkin T-cell lymphoma, the diagnosis 
being unspecified peripheral T-cell lymphoma [6] according to the WHO Classification [7]. 
Postoperatively there was no recurrence of anemia. Chest/abdominal CT scans revealed no changes 
of the right pyothorax or lymphadenopathy. The sIL2-R level decreased gradually, but still remained 
high. Ga scintigraphy showed the disappearance of abnormal uptake in the mediastinum. 
Chemotherapy was not performed because the patient strongly refused it. There were no signs of 
recurrence for 20 months after surgery, but the patient died in September 2007 because of rapid 
deterioration of respiratory function. At autopsy, malignant lymphoma was not detected in the residual 
stomach, lungs, bone marrow, or lymph nodes. In the upper lobe of the left lung, there was an 
epithelioid cell granuloma accompanied by caseous necrosis which was positive for Ziehl-Neelsen stain.  
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A chronic right pyothorax was also noted, but there were no findings suggesting malignant lymphoma 
or tuberculosis. 
Discussion 
Approximately 10% of all malignant lymphomas originate from the gastrointestinal 
tract, with 60–80% of gastrointestinal malignant lymphomas arising from the stomach 
and most of these tumors being derived from B cells [8]. On the other hand, malignant 
T-cell lymphoma of gastric origin is rare, accounting for approximately 6% of gastric 
malignant lymphomas [1]. 
Malignant lymphoma of the stomach is classified as primary or secondary, but it is not 
always easy to differentiate these two tumor types [8]. The diagnostic criteria of Dawson 
et al. [9] are used for malignant lymphoma of intestinal origin, although the results of 
endoscopy, CT, and Ga scintigraphy have been used for this purpose in recent years [8]. 
In our patient, preoperative bone marrow aspiration revealed CD3-positive lymphocytes 
and Ga scintigraphy showed increased uptake in the mediastinum, so secondary 
malignant lymphoma was initially suspected and adult T-cell leukemia/lymphoma was 
considered to be the underlying disease. However, it was considered necessary to 
differentiate the tumor from gastric metastases of PAL and PEL (EBV-related malignant 
lymphomas or body-cavity based lymphoma) [10] because of the coexistence of chronic 
tuberculous pyothorax and the positive tests for EBV antibody. The possibility of these 
diseases was ruled out almost completely and the possibility of secondary malignant 
lymphoma was concluded to be low because the patient was negative for HTLV-1 
antibody, because EBV-related malignant lymphoma or PAL and PEL usually arise from 
B cells and rarely from T cells, because pyothorax cytology revealed no lymphoma cells, 
and because CT detected no tumor around the pyothorax either before or after surgery. A 
diagnosis of malignant lymphoma of gastric origin was considered to be very likely 
because postoperative Ga scintigraphy only revealed abnormal uptake in the 
mediastinum, gastroscopy and CT showed no abnormalities, the diagnostic criteria of 
Dawson et al. were fulfilled, and there was no recurrence for 20 months postoperatively. 
Our patient was diagnosed as having Cotswolds stage IV malignant T-cell lymphoma 
because preoperative Ga scintigraphy showed increased uptake in the mediastinum and 
because iliac marrow aspiration suggested partial infiltration of CD3-positive 
lymphocyte-like cells. However, autopsy found no malignant lymphoma in the thoracic 
cavity, mediastinum or bone marrow, so the CD3-positive lymphocytes observed in the 
marrow before surgery were regarded as non-tumorous. The persistently high sIL2-R 
level noted during observation was not considered to be ascribable to recurrent malignant 
lymphoma, but rather to chronic inflammation associated with tuberculosis and chronic 
pyothorax. 
Malignant lymphoma of gastric origin is treated by a combination of surgery, 
chemotherapy and radiotherapy. Total gastrectomy has been recommended as the 
procedure of first choice because multiple lesions are common and because there is a high 
rate of recurrence from the residual stomach [8]. In our patient, only gastric wedge 
resection of the tumor was done because Cotswolds stage IV malignant lymphoma was 
diagnosed preoperatively and the patient’s general condition was poor. Postoperative 
chemotherapy was not performed because the patient refused it. 
Among non-Hodgkin lymphoma, the prognosis of malignant B-cell lymphoma of 
gastric origin is relatively favorable. If the tumor is localized, it may be possible to cure it 
by local therapy alone [1, 8]. However, unspecified peripheral T-cell lymphoma does not  
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respond well to treatment, and the 1-year survival rate is low at around 20–30% [7]. 
Malignant T-cell lymphoma of gastric origin tends to undergo transformation to 
leukemia and its prognosis is poor (35.1% of patients die within 1 year) [1]. However, it 
has also been reported that HTLV-1-negative patients with gastric T-cell lymphoma can 
have long survival [11]. In fact, there were no signs of recurrence during the follow-up 
period of 20 months without treatment, but our patient eventually died of respiratory 
insufficiency due to his other underlying diseases. If this had not happened, long survival 
could have been expected because it was demonstrated at autopsy that radical cure had 
been obtained by surgery. 
 
 
 
Table 1. Hematology findings on admission 
TP, g/dl  7.3 
Alb, g/dl  3.5 
GOT, IU/l  23 
GPT, IU/l  12 
LDH, IU/l  163 
ALP, IU/l  183 
BUN, mg/dl  10 
Cr, mg/dl  0.78 
Na, mEq/l  141 
K, mEq/l  105 
Cl, mEq/l  3.4 
WBC, /μl  7,760 
Stab, %  0 
Seg, %  74.0 
Eos, %  1.0 
Baso, %  1.0 
Lymph, %  19.0 
Mono, %  5.0 
RBC, ×10
4/μl 281 
Hb, g/dl  6.1 
Ht, %  21.5 
Plt, ×10
4/μl 47.1 
AFP, ng/ml  2.3 
CEA, ng/ml  6.1 
CA 19-9, U/ml  24.3 
IL2-R, U/ml  1,500 
EBV Ab  (+) 
HTLV-1 Ab  (–) 
H. pylori Ab  (–) 
HIV Ab  (–) 
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Fig. 1. a A shadow protruding from the right chest wall into the thoracic cavity and a nodular shadow 
in the left upper lung field were observed (arrows). b An obsolete empyema was observed along the 
right lower chest wall (arrows). 
 
 
Fig. 2. a A type 2 tumor about 3 cm in diameter was seen in the vaulted region of the stomach. b An 
enhanced tumor was seen in the posterior wall of the vaulted region (arrows). 
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Fig. 3. a Large atypical lymphocytes were increased diffusely in the tumor. b Immunopathologically 
CD3 positive. 
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